Clinical Trial Update: Quantification of Change in MG Disease Activity in Individuals With Generalized Myasthenia Gravis (gMG) After Administration of VYVGART® or VYVGART Hytrulo® Using BioDigit MG

View source ↗

Summary

Clinical trial update evaluating change in generalized myasthenia gravis activity after administration of VYVGART or VYVGART Hytrulo using BioDigit MG; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• VYVGART (EFGARTIGIMOD ALFA)
• VYVGART HYTRULO (EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT))

Snippet

Sponsor: BioSensics | Conditions: Myasthenia Gravis Generalized | Status: NOT_YET_RECRUITING